Anavex Life Sciences Corp. | Balance Sheet
Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
345.10
7,262.10
15,291.00
9,186.80
27,440.30
22,930.60
Total Accounts Receivable
-
-
76.80
79.30
9.70
40.20
Other Current Assets
48.40
89.10
100.80
180.10
335.90
1,251.80
Total Current Assets
393.40
7,351.30
15,468.70
9,446.30
27,785.90
24,222.60
Net Property, Plant & Equipment
-
2.20
1.30
-
-
-
Other Assets
-
-
-
52.40
52.40
153.50
Total Assets
393.40
7,353.50
15,469.90
9,498.70
27,838.30
24,376.10
ST Debt & Current Portion LT Debt
210.90
192.10
85.20
-
-
Accounts Payable
1,741.80
-
-
-
3,584.30
Other Current Liabilities
0.00
1,249.10
2,575.30
3,190.50
-
Total Current Liabilities
1,952.70
1,441.10
2,660.60
3,190.50
3,584.30
Long-Term Debt
904.00
5,719.70
0.30
-
-
Total Liabilities
2,856.70
7,160.90
2,660.90
3,190.50
3,584.30
Common Equity (Total)
2,463.20
192.60
12,809.00
6,308.20
24,254.00
Total Shareholders' Equity
2,463.20
192.60
12,809.00
6,308.20
24,254.00
Total Equity
2,463.20
192.60
12,809.00
6,308.20
24,254.00
Liabilities & Shareholders' Equity
393.40
7,353.50
15,469.90
9,498.70
27,838.30
About Anavex Life Sciences
View Profile
